These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. Cunningham AL; Nelson PA; Fathman CG; Merigan TC J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967 [TBL] [Abstract][Full Text] [Related]
3. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro. Cunningham AL; Noble JR J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000 [TBL] [Abstract][Full Text] [Related]
4. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses. Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660 [TBL] [Abstract][Full Text] [Related]
5. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. Carmack MA; Yasukawa LL; Chang SY; Tran C; Saldana F; Arvin AM; Prober CG J Infect Dis; 1996 Nov; 174(5):899-906. PubMed ID: 8896488 [TBL] [Abstract][Full Text] [Related]
6. Role of macrophage D-region antigens and T-lymphocyte differentiation antigens in induction of gamma interferon. Cunningham AL; Basham TY; Para MF; Merigan TC J Interferon Res; 1985; 5(3):477-91. PubMed ID: 2997338 [TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598 [TBL] [Abstract][Full Text] [Related]
8. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses. Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840 [TBL] [Abstract][Full Text] [Related]
9. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems. Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522 [TBL] [Abstract][Full Text] [Related]
10. Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D. Wyckoff JH; Osmand AP; Eisenberg RJ; Cohen GH; Rouse BT Immunobiology; 1988 May; 177(2):134-48. PubMed ID: 2456985 [TBL] [Abstract][Full Text] [Related]
12. An M2 Rather than a T Lee DH; Ghiasi H J Virol; 2018 May; 92(10):. PubMed ID: 29491152 [TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T lymphocytes from infected mice. Characterization of T cell clones. Johnson RM; Lancki DW; Fitch FW; Spear PG J Immunol; 1990 Jul; 145(2):702-10. PubMed ID: 1973187 [TBL] [Abstract][Full Text] [Related]
14. Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis. Cunningham AL; Merigan TC J Immunol; 1984 Jan; 132(1):197-202. PubMed ID: 6418797 [TBL] [Abstract][Full Text] [Related]
15. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease. Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519 [TBL] [Abstract][Full Text] [Related]
16. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. Burchett SK; Corey L; Mohan KM; Westall J; Ashley R; Wilson CB J Infect Dis; 1992 May; 165(5):813-8. PubMed ID: 1314868 [TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. Mikloska Z; Cunningham AL J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620 [TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654 [TBL] [Abstract][Full Text] [Related]
20. Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex. Westra DF; Verjans GMGM; Osterhaus ADME; van Kooij A; Welling GW; Scheffer AJ; The TH; Welling-Wester S J Gen Virol; 2000 Aug; 81(Pt 8):2011-2015. PubMed ID: 10900040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]